Silence Therapeutics plc - ADS (SLN)

CUSIP: 82686Q101

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / ADS
Total 13F shares
2,261,433
Share change
-285,603
Total reported value
$56,411,000
Price per share
$25.78
Number of holders
6
Value change
-$6,759,832
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 82686Q101?
CUSIP 82686Q101 identifies SLN - Silence Therapeutics plc - ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Silence Therapeutics plc - ADS (SLN) as of Q2 2021

As of 30 Jun 2021, Silence Therapeutics plc - ADS (SLN) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,261,433 shares. The largest 6 holders included Lombard Odier Asset Management (USA) Corp, BVF INC/IL, ADAGE CAPITAL PARTNERS GP, L.L.C., Consonance Capital Management LP, MORGAN STANLEY, and SG Americas Securities, LLC. This page lists 6 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.